title: Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancer.
abstract: BACKGROUND
  Fatigue is the most distressing side effect of radiation therapy, and its progression etiology is unknown.
  
  
  OBJECTIVE
  This study describes proteome changes from sera of fatigued men with non-metastatic prostate cancer receiving external beam radiation therapy (EBRT).
  
  
  METHODS
  Fatigue scores, measured by the Functional Assessment of Chronic Illness Therapy-Fatigue, and serum were collected from 12 subjects at baseline (before EBRT) and at midpoint (Day 21) of EBRT. Depleted sera from both time points were analyzed using two-dimensional difference gel electrophoresis, and up/down regulated proteins were identified using liquid chromatography-tandem mass spectrometry. Western blot analyses confirmed the protein changes observed.
  
  
  RESULTS
  Results showed that apolipoprotein (Apo)A1, ApoE, and transthyretin (TTR) consistently changed from baseline (Day 0) to midpoint (Day 21). The mean ApoE level of subjects with high change in fatigue (HF: n = 9) increased significantly from baseline to midpoint and were higher than in subjects with no change in fatigue. The mean ApoA1 level was higher in HF subjects at baseline and at midpoint than in no fatigue subjects at both time points. The mean TTR level of no fatigue subjects was higher at baseline and midpoint than in HF subjects.
  
  
  CONCLUSIONS
  These ApoE, ApoA1, and TTR results may assist in understanding pathways that can explain fatigue progression etiology in this clinical population.
authors.affiliation: National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: nada.lukkahatai@nih.gov.
authors.forename: Nada
authors.initials: N
authors.lastname: Lukkahatai
authors.affiliation: National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Sajni
authors.initials: S
authors.lastname: Patel
authors.affiliation: National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Marjan
authors.initials: M
authors.lastname: Gucek
authors.affiliation: National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Chao-Pin
authors.initials: CP
authors.lastname: Hsiao
authors.affiliation: National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Leorey N
authors.initials: LN
authors.lastname: Saligan
mesh_terms: D000368:Aged; D016632:Apolipoprotein A-I / Q000097:blood; D001057:Apolipoproteins E / Q000097:blood; D015153:Blotting, Western; D002853:Chromatography, Liquid; D018450:Disease Progression; D005221:Fatigue / Q000097:blood* / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011228:Prealbumin / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000097:blood* / Q000532:radiotherapy*; D040901:Proteomics / Q000379:methods; D012720:Severity of Illness Index; D053719:Tandem Mass Spectrometry; D013997:Time Factors; D057825:Two-Dimensional Difference Gel Electrophoresis
chemical_list: C505693:APOA1 protein, human; D016632:Apolipoprotein A-I; D001057:Apolipoproteins E; D011228:Prealbumin
keywords: External beam radiation therapy; Western blot; fatigue; prostate cancer; quantitative proteomics
references.citation: J Natl Cancer Inst. 2008 Aug 20;100(16):1155-66
references.pmid: 18695134
references.citation: Anesthesiology. 2008 Feb;108(2):314-23
references.pmid: 18212577
references.citation: Anal Biochem. 1984 Apr;138(1):141-3
references.pmid: 6731838
references.citation: Proteomics. 2006 Mar;6(6):1963-75
references.pmid: 16470659
references.citation: Proteomics Clin Appl. 2013 Jan;7(1-2):109-22
references.pmid: 23027708
references.citation: Brain Behav Immun. 2007 Mar;21(3):251-8
references.pmid: 17008048
references.citation: Bioinformatics. 2004 Mar 22;20(5):777-85
references.pmid: 14751995
references.citation: J Natl Cancer Inst. 2002 Oct 16;94(20):1576-8
references.pmid: 12381711
references.citation: J Cancer Res Ther. 2010 Oct-Dec;6(4):516-20
references.pmid: 21358092
references.citation: Brain Behav Immun. 2013 Jan;27(1):63-70
references.pmid: 23022913
references.citation: Int J Neuropsychopharmacol. 2012 Nov;15(10):1373-4
references.pmid: 22717368
references.citation: Eur J Cancer. 2009 Feb;45(3):384-92
references.pmid: 18977131
references.citation: BMC Neurol. 2005 Dec 01;5:22
references.pmid: 16321154
references.citation: Biomol NMR Assign. 2008 Dec;2(2):207-10
references.pmid: 19636906
references.citation: J Pain Symptom Manage. 2013 May;45(5):868-74
references.pmid: 23017604
references.citation: J Pain Symptom Manage. 1997 Feb;13(2):63-74
references.pmid: 9095563
references.citation: Technol Cancer Res Treat. 2002 Aug;1(4):297-304
references.pmid: 12625789
references.citation: J Biomed Biotechnol. 2010;2010:906082
references.pmid: 20029632
references.citation: J Biol Chem. 2010 Nov 19;285(47):36958-68
references.pmid: 20847045
references.citation: Mol Cell Proteomics. 2004 Apr;3(4):367-78
references.pmid: 14990683
references.citation: Methods. 2006 Apr;38(4):342-50
references.pmid: 16487723
references.citation: Nat Neurosci. 2008 Mar;11(3):301-8
references.pmid: 18297066
references.citation: Breast Cancer Res Treat. 2008 Nov;112(1):5-13
references.pmid: 18064565
references.citation: World J Urol. 2012 Apr;30(2):195-200
references.pmid: 22476558
references.citation: J Urol. 2003 Aug;170(2 Pt 1):442-6
references.pmid: 12853795
references.citation: Oncologist. 2007;12 Suppl 1:22-34
references.pmid: 17573453
references.citation: Eur Arch Psychiatry Clin Neurosci. 2010 Sep;260(6):499-506
references.pmid: 19997739
references.citation: Psychol Med. 2004 Oct;34(7):1289-97
references.pmid: 15697055
references.citation: Proteomics. 2005 Dec;5(18):4713-8
references.pmid: 16281180
references.citation: Clin Cancer Res. 2009 Sep 1;15(17):5534-40
references.pmid: 19706826
references.citation: Anticancer Res. 2007 May-Jun;27(3A):1247-55
references.pmid: 17593616
references.citation: Neuron. 2008 Jun 12;58(5):681-93
references.pmid: 18549781
references.citation: J Natl Cancer Inst. 2005 Feb 16;97(4):310-4
references.pmid: 15713967
references.citation: FEBS J. 2010 Oct;277(19):4066-75
references.pmid: 20735474
references.citation: Clin Chim Acta. 2012 Jul 11;413(13-14):1098-106
references.pmid: 22446497
references.citation: Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S2-6
references.pmid: 19955909
references.citation: J Rehabil Res Dev. 2005 May-Jun;42(3):391-9
references.pmid: 16187251